FSA & HSA Eligible
Microdose: The Easy Way to Start a GLP-1
Noom Microdose GLP-1Rx Program helps you lose weight and get healthy.
- Affordable – plans start at $791
- Friendly – designed to minimize side effects
- Paired with behavior change and coaching – for results that last
Why Noom Microdose?
Noom Microdose GLP-1Rx Program is the easy way to start on GLP-1s, providing a smaller dose compared to our standard GLP‑1 plan. It’s designed to be easy on your body and to kickstart your weight-loss goals.
Plans start at just $791
Affordable care that provides real results, including meds, clinical visits, and ongoing support
Lose up to 17 pounds in 60 days2
Lose weight comfortably with dosing tailored to your body and pace.
Behavior change and coaching
Get access to Noom GLP-1 Companion for extra support
Whole‑health wins
Optimize your biomarkers, health, and vitality while losing weight
How it Works
1
Take a brief intake survey
Share your health history and weight-loss goals and receive your clinical plan.
2
Connect with an expert clinician
A clinician will quickly evaluate your results and provide a prescription all online, if clinically appropriate.
3
Start losing weight with your customized Microdose plan
Get medication shipped, if eligible, and begin your journey with the lowest effective dose that delivers results.3
4
Ongoing care and medication
Receive continuous monitoring and adjustments, with unlimited access to your clinician and medication refills, where clinically appropriate.
Success Stories
Real members, real results with Noom Microdose
“My medication has removed my cravings for sugar. I am down 16 pounds.”
16 pounds lost, 4 weeks on Noom
Laura
“Noom provided me with the medication which I could not get through Medicare. I have learned the tricks to better eating and life in general.”
32 pounds lost, 15 weeks on Noom
Steve M.
Read More About GLP-1s
Take Your First Microstep.
Lose weight with Noom Microdose GLP-1Rx Program —backed by coaching, community, and plans that start at $791.
Individual results vary. Medication prescribed only if clinically appropriate.
Frequently Asked Questions
How does microdosing a GLP-1 work?
Noom’s Microdose Program uses lower doses of medication designed by our Chief Medical Officer to lose weight, reduce side effects, preserve muscle mass, and support sustainable weight management.
How is Noom Microdose GLP-1Rx Program different from Noom’s other GLP-1 programs?
The Microdose Program utilizes lower doses of medication. It comes with the same comprehensive Noom program and clinical care and support as our other Med programs.
Will I still lose weight on a smaller dose?
It is absolutely possible to reach your weight-loss goals with a smaller dose. For example, members using Microdose GLP-1Rx lose up to 17 pounds in 60 days2. The key is finding your optimal dose, not the maximum dose.
What kind of support comes with Noom Microdose GLP-1Rx Program?
You’ll have access to our clinical team, receive dose optimization guidance, coaching support, and a community of members on similar journeys.
How long does it take to see results?
Most members begin losing weight within the first month. The gradual approach is designed to drive sustainable results that are easier to maintain long-term.
1Initial 4 week subscription from $79 plus tax and $199 per month plus tax for 12 week subscription thereafter. New pricing for new accounts only effective as of March 31, 2026.
2 Weight loss represents the top 25th percentile of self-reported data from 1,185 Noom Med users prescribed compounded GLP-1s. Average weight loss was 13 pounds.
3 Not all medications are available for home delivery. Availability of home delivery will depend on your insurance or cash pay status. If your clinician feels compounded medications are clinically appropriate for you, any compounded medications are not approved by the FDA or reviewed for quality, safety or efficacy. Novo Nordisk, Inc. is the only United States company with FDA-approved products containing semaglutide, identified under the trade names Rybelsus®, Ozempic® and Wegovy®. Lilly USA LLC is the only United States company with FDA-approved products containing tirzepatide identified under the trade names Zepbound® and Mounjaro®